Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pharmagen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
The company has return on total asset (ROA) of (0.5891) % which means that it has lost $0.5891 on every $100 spent on assets. This is way below average. Pharmagen's management efficiency ratios could be used to measure how well Pharmagen manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -4.83 in 2024. Return On Capital Employed is likely to drop to 0.26 in 2024. Total Assets is likely to drop to about 1.3 M in 2024. Net Tangible Assets is likely to rise to about (6.6 M) in 2024
Net Loss is likely to rise to about (5.5 M) in 2024
Pharmagen Workforce Comparison
Pharmagen is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 770,085. Pharmagen adds roughly 24.0 in number of employees claiming only tiny portion of equities under Health Care industry.
The company has Profit Margin (PM) of (1.33) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.31) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.31.
The output start index for this execution was zero with a total number of output elements of sixty-one. Pharmagen Price Series Summation is a cross summation of Pharmagen price series and its benchmark/peer.
The success or failure of an entity such as Pharmagen often depends on how effective the management is. Pharmagen management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Pharmagen management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Pharmagen management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Please note, the imprecision that can be found in Pharmagen's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Pharmagen. Check Pharmagen's Beneish M Score to see the likelihood of Pharmagen's management manipulating its earnings.
Pharmagen Workforce Analysis
Traditionally, organizations such as Pharmagen use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Pharmagen within its industry.
Pharmagen Manpower Efficiency
Return on Pharmagen Manpower
Revenue Per Employee
200.5K
Net Loss Per Employee
250K
Additional Tools for Pharmagen Stock Analysis
When running Pharmagen's price analysis, check to measure Pharmagen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmagen is operating at the current time. Most of Pharmagen's value examination focuses on studying past and present price action to predict the probability of Pharmagen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmagen's price. Additionally, you may evaluate how the addition of Pharmagen to your portfolios can decrease your overall portfolio volatility.